AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401. A total of 100 filers reported holding AVANIR PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $9,882,000 | -77.1% | 582,954 | -83.9% | 0.02% | -80.7% |
| Q3 2014 | $43,179,000 | +57.2% | 3,622,397 | -25.6% | 0.11% | +43.4% |
| Q2 2014 | $27,459,000 | +44.5% | 4,868,557 | -6.0% | 0.08% | +38.2% |
| Q1 2014 | $19,009,000 | +62.6% | 5,179,613 | +48.8% | 0.06% | +48.6% |
| Q4 2013 | $11,692,000 | +560.6% | 3,479,955 | +731.5% | 0.04% | +516.7% |
| Q3 2013 | $1,770,000 | +26.2% | 418,520 | +37.3% | 0.01% | +50.0% |
| Q2 2013 | $1,403,000 | – | 304,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,436,053 | $10,329,000 | 1.78% |
| GREAT POINT PARTNERS LLC | 200,000 | $846,000 | 0.59% |
| Tekla Capital Management LLC | 960,000 | $4,070,000 | 0.45% |
| Artal Group S.A. | 3,100,000 | $13,113,000 | 0.43% |
| Baker Brothers Advisors | 4,428,591 | $18,733,000 | 0.27% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,446,839 | $6,120,000 | 0.24% |
| FORTALEZA ASSET MANAGEMENT INC/ | 96,545 | $408,000 | 0.21% |
| EAM Investors, LLC | 236,609 | $1,003,000 | 0.20% |
| ASCEND CAPITAL, LLC | 979,370 | $4,143,000 | 0.15% |
| Orbimed Advisors | 1,863,400 | $7,882,000 | 0.14% |